We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Palm-Sized Device Detects Disease-Related Genetic Material In 45 Minutes

By LabMedica International staff writers
Posted on 19 Jun 2025

Polymerase chain reaction (PCR) and real-time immunoassays are widely used for accurate diagnostics, but they come with key limitations. More...

Their dependence on time-intensive processes, costly thermal cyclers, and trained personnel makes them impractical for rapid outbreak response, early cancer detection, or bedside use, especially in low-resource environments. To address these barriers, researchers have introduced a compact, palm-sized device that bypasses conventional amplification steps and directly converts biological signals into detectable DNA fragments using a tandem nuclease cascade.

Developed by scientists from the National University of Singapore (NUS, Singapore), this innovative platform is called NAPTUNE—short for Nucleic Acids and Protein biomarkers Testing via Ultra-sensitive Nucleases Escalation. The system was designed as a true point-of-care assay that can detect extremely low levels of nucleic acid and protein disease markers in under 45 minutes. According to findings published in Nature Communications, it eliminates the need for laboratory infrastructure or complex sample preparation. NAPTUNE operates using a two-stage enzymatic cascade. The first stage leverages APE1, a human DNA-repair enzyme, to identify abasic (AP) sites engineered within a reporter duplex. This enzyme cleaves the duplex and releases 5′-phosphorylated DNA guide strands. In the second stage, these DNA guides activate a heat-stable Argonaute protein derived from Pyrococcus furiosus (PfAgo), which then cleaves fluorophore-quencher probes in a chain reaction. The resulting fluorescence is directly proportional to the concentration of the disease target.

This enzymatic relay system dramatically enhances detection sensitivity—from the femtomolar range achievable by APE1 alone to the attomolar (10⁻¹⁸ M) range—establishing a new standard for amplification-free detection. To ensure the technology’s portability and ease of use, the researchers miniaturized the NAPTUNE assay into a single-use tube equipped with a battery-powered heater and Bluetooth-enabled fluorescence reader. Weighing less than 200 grams, the device streams real-time diagnostic results to a mobile application, making it suitable for virus tracking, cancer screening, and other clinical uses outside traditional labs. Currently, the NUS team is validating the NAPTUNE platform for tuberculosis detection using sputum samples. They are also exploring lyophilized reagent kits that can withstand tropical climates, and working on additional formats such as electrochemical and lateral-flow readouts. These efforts aim to accelerate the tool’s commercial rollout and broaden its application in decentralized diagnostics worldwide.

“By chaining two naturally occurring nucleases in an orthogonal circuit, we achieve PCR-class sensitivity without touching a thermocycler,” said NUS Assistant Professor Chunyi HU. “Our vision is to place laboratory-grade diagnostics directly into the hands of community health workers.”

Related Links:
NUS


Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Serological Pipet Controller
PIPETBOY GENIUS
New
Staining Management Software
DakoLink
New
Automatic Hematology Analyzer
LABAS F9000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: Micrograph showing the distribution of misfolded proteins in myeloma cells (Photo courtesy of Helmholtz Munich)

Novel Method Tracks Cancer Treatment in Cells Without Dyes or Labels

Multiple myeloma is a blood cancer that affects plasma cells in the bone marrow, leading to abnormal protein production, weakened immunity, and organ damage. Traditional methods for evaluating myeloma... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.